Patients with adrenal gland diseases are left without a life-saving drug
Since March 2026, Russian pharmacies have been experiencing supply disruptions of the drug “Ziflucort”, which is included in the list of essential medicines (EML) and is indicated for people with adrenal gland disorders. This was reported to “Kommersant” by patients themselves, who faced a lack of the medication on the shelves. The possible reason for…
